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Background
In comparison to the western world, aggressive non-
Hodgkin’s lymphoma (NHL) including primary central
nervous system (CNS) lymphoma, as AIDS-defining dis-
ease, is less common in sub-Saharan Africa even with
its high HIV/AIDS prevalence. We studied the occur-
rence of HIV/AIDS-related lymphomas in Nigerian
patients with a view toward highlighting the incidence.
Patients and method
Consecutive cases of histologically and/or cytologically
confirmed lymphoma screened for HIV (after appropri-
ate counseling) and seen between January 2003 and
December 2009 were the subjects. Types and treatment
outcome of lymphoma in the HIV-positive group were
further studied. Data were analyzed using appropriate
descriptive and inferential statistics.
Results
There were 161 cases comprising NHL, 42 (25.5%); HL,
15 (9.3%), and BL, 104, (64.6%). Seven (4.3%), aged 2-49
(median = 41) years were retroviral positive. Of these,
4 (3 males, 1 female, aged 28-49 (median = 38.5) years)
had NHL, 2 (both females) HL, and 1 case, a 2-year-old
boy with HIV since birth, had Burkitt’sa n da nH I V -
positive mother. All, except one female with stage 1 HL,
presented late (at least clinical stage IIIb). Three patients
with NHL and 1 with late-stage HL succumbed to their
disease within 1-3 weeks of hospital admission. The
remaining 3 patients had been responding satisfactorily
to chemotherapy (CHOP for NHL, ABVD for HL, and
COM for Burkitt’s lymphoma.)
Conclusion
Compared to earlier reports from Nigeria, the AIDS-
related lymphomas rate of 4.3% in the series indicated
rising incidence. AIDS-associated BL of 0.1%, in spite of
high background prevalence of Burkitt’sl y m p h o m a
(>60% of lymphomas), supported its relative rarity. With
longer survival and longer immunosuppression, closely
following up AIDS patients on HAART would be justi-
fied, as more cases of AIDS-related lymphomas may
possibly emerge in the future.
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